News
Early detection and new biomarkers are changing how we manage acute kidney injury—and its link to chronic kidney disease.
Based on these numbers, the researchers estimated that 5-year cumulative risks of recurrent events were 17.4% for ischemic ...
Discover 8 key causes of bloody cough from infections to lung conditions. Learn when coughing blood needs medical attention ...
Parade. You are what you eat, so you might want to eat more berries. Yes, really! Despite their natural sugar content, ...
In-Depth MemoDefend Review Reveals Ingredient Science, Real User Results, Pricing Breakdown, and Long-Term Brain Health ...
Entomologist Dr. Jessica Ware joins WIRED to answer the internet's burning questions about the world of insects. Are cockroaches so resilient that they'd survive a nuclear war? Why do praying mantis ...
AstraZeneca's anticoagulant reversal agent Andexxa was given an accelerated approval by the FDA in 2018, but the company's plan to get that upgraded to a full approval is facing some pushback.
We propose that this force-dependent regulation of nucleotide exchange is the basic mechanism of gating behaviour — a key regulation for the efficient hand-over-hand movement. The regulatory ...
Bayer is pressing ahead with a phase 3 trial of its oral Factor XIa inhibitor asundexian, a new anticoagulant, despite missing efficacy targets in two mid-stage studies. The OCEANIC trial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results